Cargando…
Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672036/ https://www.ncbi.nlm.nih.gov/pubmed/37999393 http://dx.doi.org/10.3390/md21110569 |
_version_ | 1785140296434057216 |
---|---|
author | Chukwudulue, Uche M. Barger, Natalia Dubovis, Michael Luzzatto Knaan, Tal |
author_facet | Chukwudulue, Uche M. Barger, Natalia Dubovis, Michael Luzzatto Knaan, Tal |
author_sort | Chukwudulue, Uche M. |
collection | PubMed |
description | The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms whose natural products are yet to be explored. Among these underexplored marine organisms are macroalgae and their symbiotic microbes, such as Bacillota, a phylum of mostly Gram-positive bacteria previously known as Firmicutes. Macroalgae-associated Bacillota often produce chemical compounds that protect them and their hosts from competitive and harmful rivals. Here, we summarised the natural products made by macroalgae-associated Bacillota and their pharmacological properties. We discovered that these Bacillota are efficient producers of novel biologically active molecules. However, only a few macroalgae had been investigated for chemical constituents of their Bacillota: nine brown, five red and one green algae. Thus, Bacillota, especially from the marine habitat, should be investigated for potential pharmaceutical leads. Moreover, additional diverse biological assays for the isolated molecules of macroalgae Bacillota should be implemented to expand their bioactivity profiles, as only antibacterial properties were tested for most compounds. |
format | Online Article Text |
id | pubmed-10672036 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106720362023-10-30 Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae Chukwudulue, Uche M. Barger, Natalia Dubovis, Michael Luzzatto Knaan, Tal Mar Drugs Review The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms whose natural products are yet to be explored. Among these underexplored marine organisms are macroalgae and their symbiotic microbes, such as Bacillota, a phylum of mostly Gram-positive bacteria previously known as Firmicutes. Macroalgae-associated Bacillota often produce chemical compounds that protect them and their hosts from competitive and harmful rivals. Here, we summarised the natural products made by macroalgae-associated Bacillota and their pharmacological properties. We discovered that these Bacillota are efficient producers of novel biologically active molecules. However, only a few macroalgae had been investigated for chemical constituents of their Bacillota: nine brown, five red and one green algae. Thus, Bacillota, especially from the marine habitat, should be investigated for potential pharmaceutical leads. Moreover, additional diverse biological assays for the isolated molecules of macroalgae Bacillota should be implemented to expand their bioactivity profiles, as only antibacterial properties were tested for most compounds. MDPI 2023-10-30 /pmc/articles/PMC10672036/ /pubmed/37999393 http://dx.doi.org/10.3390/md21110569 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chukwudulue, Uche M. Barger, Natalia Dubovis, Michael Luzzatto Knaan, Tal Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title | Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title_full | Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title_fullStr | Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title_full_unstemmed | Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title_short | Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae |
title_sort | natural products and pharmacological properties of symbiotic bacillota (firmicutes) of marine macroalgae |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672036/ https://www.ncbi.nlm.nih.gov/pubmed/37999393 http://dx.doi.org/10.3390/md21110569 |
work_keys_str_mv | AT chukwudulueuchem naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae AT bargernatalia naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae AT dubovismichael naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae AT luzzattoknaantal naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae |